Zobrazeno 1 - 10
of 3 037
pro vyhledávání: '"response prediction"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-26 (2024)
Abstract This research introduces an advanced method for predicting seismic responses and hysteresis curves of instrumented bridge piers and bearings under various loading conditions, leaning solely on a single deep learning architecture and the same
Externí odkaz:
https://doaj.org/article/98a55fd6407041a1b568ce9b99c538bc
Autor:
Blanca Ferrer-Lores, Alfonso Ortiz-Algarra, Alfonso Picó-Peris, Alejandra Estepa-Fernández, Fuensanta Bellvís-Bataller, Glen J. Weiss, Almudena Fuster-Matanzo, Juan Pedro Fernández, Ana Jimenez-Pastor, Rafael Hernani, Ana Saus-Carreres, Ana Benzaquen, Laura Ventura, José Luis Piñana, Ana Belén Teruel, Alicia Serrano-Alcalá, Rosa Dosdá, Pablo Sopena-Novales, Aitana Balaguer-Rosello, Manuel Guerreiro, Jaime Sanz, Luis Martí-Bonmatí, María José Terol, Ángel Alberich-Bayarri
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Background This multicentre retrospective observational study aims to develop imaging-based prognostic and predictive models for relapsed/refractory (R/R) B-cell lymphoma patients undergoing CAR-T therapy by integrating clinical data and ima
Externí odkaz:
https://doaj.org/article/0057ba293b9c45989ef0c7a2fb4073b2
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Structural health monitoring (SHM) is a technique used to evaluate the safety of a structure based on the structural response. In the SHM, sensors may fail to measure the structural response, or data loss can occur during the data transmissi
Externí odkaz:
https://doaj.org/article/e1dbead4316b4e3b91841b0a9211b229
Publikováno v:
BMC Biology, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract Background Accurate and robust drug response prediction is of utmost importance in precision medicine. Although many models have been developed to utilize the representations of drugs and cancer cell lines for predicting cancer drug response
Externí odkaz:
https://doaj.org/article/f1c9552d84e14eafa67c1b5380b0805d
Publikováno v:
BMC Medical Imaging, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background To investigate whether radiomics models derived from pretreatment CT could help to predict response to immunotherapy in oral squamous cell carcinoma (OSCC). Methods Retrospectively, a total of 40 patients with measurable OSCC were
Externí odkaz:
https://doaj.org/article/37b6f576765247db975f1271cfe79f04
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 118-125 (2024)
Ensuring the preventive anti-plague vaccination and the rational use of immunoprophylaxis means entail an adequate and timely assessment of their effectiveness. In the absence of mass cases of plague, it is impossible to objectively assess the actual
Externí odkaz:
https://doaj.org/article/5f445a787afc45f39b231785215a46c4
Publikováno v:
Journal of Integrative Bioinformatics, Vol 21, Iss 3, Pp 1093-8 (2024)
Drug therapy remains the primary approach to treating tumours. Variability among cancer patients, including variations in genomic profiles, often results in divergent therapeutic responses to analogous anti-cancer drug treatments within the same coho
Externí odkaz:
https://doaj.org/article/1641c9b3c5c34817b001ea2ca0b7a5cf
Publikováno v:
Medical Journal of Babylon, Vol 21, Iss 2, Pp 383-388 (2024)
Background:Knowing predictors of pregnancy in assistant reproductive technology, knowing of predictors of pregnancy is helpful for clinicians to individualize treatment 14 Plans and improve patient counseling, and for patients to decide whether to un
Externí odkaz:
https://doaj.org/article/25c9d30c4f7844008355982b47359849
Publikováno v:
Onco, Vol 4, Iss 3, Pp 143-162 (2024)
As precision medicine such as targeted therapy and immunotherapy often have limited accessibility, low response rate, and evolved resistance, it is urgent to develop simple, low-cost, and quick-turnaround personalized diagnostic technologies for drug
Externí odkaz:
https://doaj.org/article/2de7fac8377548099f7b8e31f963a18b
Publikováno v:
Biomolecules & Biomedicine (2024)
Immune checkpoint inhibitors produce durable antitumor effects in various cancers, but not all patients respond. High tumor mutational burden (TMB) is a known predictor of clinical benefit. In this study, we focused on the MHC-I-dependent neoantigen
Externí odkaz:
https://doaj.org/article/fafcced7d135481cbc92ac08bc8da603